Mean FA of a patient with vacuolating megalencephalic leukoencephalopathy and of control subjects

Region of InterestMean FAFA Decrease (%)
VML PatientControl Subjects (n = 2)
10.13 ± 0.040.14 ± 0.017.1
20.16 ± 0.010.21 ± 0.0723.8
30.26 ± 0.050.34 ± 0.0423.5
40.340.40 ± 0.0815
  • Note.—FA indicates fractional anisotropy; VML, vacuolating megalencephalic leukoencephalopathy; locations of regions of interest are depicted in Figure 4.